A report by a consumer has led to the recall of 10 lots of Introvale birth control by Sandoz, a unit of Novartis AG. The recall comes after it was shown that white placebo pills were placed in the wrong row of the card, possibly making the contraceptive useless, according to MSNBC.com.birth control 6851026 300x203 Packaging Flaw Leads to Introvale Birth Control Recall

While these placebo pills are white, making them distinct from the peach-colored active pills, the chance that a consumer may take the wrong medication for several days is great enough to warrant a recall. This particular brand of birth control uses a card with 13 rows containing the medication, with the white placebo tablets placed in the final row for use in the 13th week. The U.S. Food and Drug Administration (FDA) has stated that if a consumer finds a placebo tablet anywhere other than the final row, she should immediately begin using a non-hormonal contraceptive.

The lot numbers that have been recalled are LF00478C, LF00479C, LF00551C, LF00552C, LF00687C, LF00688C, LF00763C, LF00764C, LF00765C, and LF01261C. The affected lots were distributed from January 2011 through May 2012 in the United States, but Sandoz has stated that it does not know of any adverse events that were a result of the flaw.

Drug manufacturers have a duty to produce safe and reliable pharmaceutical products that consumers can rely on without fear of injury, illness, or other adverse effects. Unfortunately, many manufacturers allow their products to go to market with serious flaws that may endanger anyone that buys them.

At Carpenter, Zuckerman & Rowley, our Los Angeles product liability lawyers can help you in your search for compensation and justice for the injuries you have received due to an unsafe or defective product. You deserve fair compensation for your losses and those who have created such dangerous products should be held responsible for their actions. For more information on how we can help you, call us today at (310) 273-1230.

Tags: , , , , , ,

Leave a Comment